Signos, a startup that uses continuous glucose monitors (CGMs) to provide personalized diet and exercise recommendations, has raised $20 million in a funding round led by Cheyenne Ventures and GV. The company is partnering with Dexcom, a leading maker of CGMs, to target people who want to lose weight without pills. Signos uses an app…